Public consultation on cancer medicines
EMA Highlights by Gary Finnegan – The EMA has launched a public consultation on its revised guidelines covering how potential cancer drugs are assessed. The document provides guidance… read more.
EMA Highlights by Gary Finnegan – The EMA has launched a public consultation on its revised guidelines covering how potential cancer drugs are assessed. The document provides guidance… read more.
EMA Highlights by Gary Finnegan – The new head of the European Medicines Agency, Guido Rasi, has promised to strengthen European rules governing medical devices in the wake… read more.
A study long used to establish causal links between hormone replacement therapy (HRT) and breast cancer is severely flawed, a group of epidemiologists have charged.
Scientists have identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of this very debilitating neurological disease. Many of the genes –… read more.
A new study from researchers at Queen Mary, University of London shows how a particular virus tricks the immune system into triggering inflammation and nerve cell damage in… read more.
Multiple sclerosis (MS), a neurodegenerative disease, causes periodic attacks of neurologic symptoms such as limb weakness and mobility defects. And while MS patients’ walking abilities and muscle strength… read more.
Researchers from the University of Southampton, in collaboration with psychologists from six other universities, have started a study to assess the impact of a new psychological therapy for… read more.
Brief adherence programmes improve diabetes test results and depression symptoms. Patients simultaneously treated for both Type 2 diabetes and depression showed improved medication compliance and significantly improved blood… read more.
It is estimated that there are 2.9 million people in the UK diagnosed with diabetes1 and the incidence is increasing, as it is across the world, all the… read more.
by Bruce Sylvester – Men and women who develop high blood pressure during middle age or who enter middle age with high blood pressure have about a 30%… read more.
by Bruce Sylvester – Stroke patients with a history of stroke or diabetes who received clot-busting drugs post-stroke have achieved better outcomes than those who did not receive… read more.
by Dr. Riyaz Shah, Consultant Medical Oncologist, Kent Oncology Centre – The ASCO 2011 Annual Meeting took place in early June at the vast McCormick Place Convention Centre… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.